Revenue Breakdown
Composition ()
No data
Revenue Streams
Zentek Ltd (ZTEK) generates its revenue primarily from IP Development , which accounts for 100.0% of total sales, equivalent to CAD 57.80K. Understanding this concentration is critical for investors evaluating how ZTEK navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Evaluating the bottom line, Zentek Ltd maintains a gross margin of -241.01%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -3673.07%, while the net margin is -3811.51%. These profitability ratios, combined with a Return on Equity (ROE) of -56.64%, provide a clear picture of how effectively ZTEK converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ZTEK competes directly with industry leaders such as ALOY and XPL. With a market capitalization of $66.35M, it holds a significant position in the sector. When comparing efficiency, ZTEK's gross margin of -241.01% stands against ALOY's 60.49% and XPL's N/A. Such benchmarking helps identify whether Zentek Ltd is trading at a premium or discount relative to its financial performance.
